ENFN - Enfusion GAAP EPS of $0.02 beats by $0.06 revenue of $39.2M beats by $0.66M
- Enfusion press release ( NYSE: ENFN ): Q3 GAAP EPS of $0.02 beats by $0.06 .
- Revenue of $39.2M (+35.0% Y/Y) beats by $0.66M .
- Fourth Quarter 2022 Outlook:-Total revenue is expected to be in the range of $39.5 million to $40.5 million vs $38.54M
- Adjusted EBITDA is expected to be in the range of $5.5 million to $6 million.
- Full Year 2022 Outlook:-Total revenue is expected to be in the range of $149.3 million to $150.3 million vs $150.69M Consensus.
- Adjusted EBITDA is expected to be in the range of $18.1 million to $18.6 million.
For further details see:
Enfusion GAAP EPS of $0.02 beats by $0.06, revenue of $39.2M beats by $0.66M